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The catalytic activity of cyclin-dependent kinases mutation or silencing of the remaining wild-type allele.
Hence, p27 is a haploinsufficient tumor suppressor. The(CDKs) is regulated by both the association with regula-
simplifying assumption that inactivating mutations of tu-tory subunits and phosphorylation. Activating subunits
mor suppressor genes are strictly recessive may haveare called cyclins, and inhibitory subunits are called CDK
excluded an important class of genes that displayinhibitors (CKIs). One CKI, p27Kip1, seems particularly
haploinsufficiency.important in coupling cell proliferation to extracellular
mitogenic stimuli. Thus, in normal proliferating cells,
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Cyclin-dependent protein kinases (CDKs) are the progression and is conserved among species from yeast
to humans, the enzyme responsible for activation hasprincipal molecular triggers of the cell division cycle and
are strictly controlled by both positive and negative regu- diverged between budding yeast and higher eukaryotes.
Mammalian CAK is itself a CDK, composed of a cata-lators. The activation of CDK-cyclin complexes requires
phosphorylation of the catalytic subunit by a CDK-acti- lytic subunit, CDK7, that forms binary complexes with
cyclin H, and ternary complexes with cyclin H and thevating kinase (CAK). Although this activating phosphor-
ylation step is common to all CDKs involved in cell cycle assembly factor MAT1. The trimeric complex also partic-
